Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
Recent progress in mRNA cancer vaccines
Ruhui Yao, C. Xie, Xiaojun Xia
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 31
Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation
Kexin Su, Lu Shi, Tao Sheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
Yisi Tang, Bao Liu, Yuting Zhang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115304-115304
Closed Access | Times Cited: 17
A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Exosome for mRNA delivery: strategies and therapeutic applications
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
Razan Masarwy, Lior Stotsky‐Oterin, Aviad Elisha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115359-115359
Closed Access | Times Cited: 14
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Modulating autophagy in the tumor microenvironment with a salinomycin-loaded liposome hybrid nanovesicle system for tumor immunotherapy
Xinying Li, Wenshang Liu, Zhenzhen Yan, et al.
Nano Today (2025) Vol. 61, pp. 102644-102644
Closed Access | Times Cited: 1
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Tailoring drug delivery systems by microfluidics for tumor therapy
Qingfei Zhang, Gaizhen Kuang, Li Wang, et al.
Materials Today (2024) Vol. 73, pp. 151-178
Closed Access | Times Cited: 12
Nucleic acid-based drugs for patients with solid tumours
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 11
An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
Lin Yang, Xuehua Chen, Ke Wang, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 727-727
Open Access | Times Cited: 11
Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo
Tian Zhang, Han Yin, Li Yu, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109804-109804
Open Access | Times Cited: 10
Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
Jiyuan Liu, Fan Yang, Jinqu Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 10
Lipid Nanocarrier‐Based mRNA Therapy: Challenges and Promise for Clinical Transformation
Wenchao Li, Chen Wang, Yifei Zhang, et al.
Small (2024) Vol. 20, Iss. 28
Closed Access | Times Cited: 8
Kinetics of RNA-LNP delivery and protein expression
Judith Müller, Nathalie Gabriele Schäffler, Thomas Kellerer, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114222-114222
Open Access | Times Cited: 8
Targeting Strategies for Site-Specific mRNA Delivery
Jiaxing Di, Pei Huang, Xiaoyuan Chen
Bioconjugate Chemistry (2024) Vol. 35, Iss. 4, pp. 453-456
Closed Access | Times Cited: 8
Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 8
Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor suppression
Min Li, Zheng Wang, Jingjing Tao, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 7
RNA nanostructures for targeted drug delivery and imaging
Laura Teodori, Marjan Omer, Jørgen Kjems
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-19
Open Access | Times Cited: 7
Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Jialiang Wang, Yaopeng Ding, K. Chul Chong, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1148-1148
Open Access | Times Cited: 7
Chimeric antigen receptor therapy meets mRNA technology
Jiacai Wu, Weigang Wu, Boping Zhou, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 2, pp. 228-240
Open Access | Times Cited: 20
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
Pei Huang, Hongzhang Deng, Changrong Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top